Rankings
▼
Calendar
ARQT Q4 2018 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ARQT
Arcutis Biotherapeutics, Inc.
$3B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-0.15
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$56,000
Balance Sheet
Total Assets
$51M
Total Liabilities
$75M
Stockholders' Equity
-$24M
Cash & Equivalents
$39M
← FY 2018
All Quarters
Q1 2019 →
